Search research articles
Contact Us
Filters
Showing results (291-300 of 335) with videos related to
Page
of 34
Sort By:
American Journal of Medical Genetics. Part A
|
April 20, 2021
Marfan syndrome resulting from a rare pathogenic FBN1 variant, ascertained through a proband with IgG4-related arteriopathy
Eric A Haan, Francois H Chamalaun, Steven A J Chamuleau, et al.
JCI Insight
|
April 19, 2019
DNA-encoded bispecific T cell engagers and antibodies present long-term antitumor activity
Alfredo Perales-Puchalt, Elizabeth K Duperret, Xue Yang, et al.
Cancer Research
|
October 6, 2018
Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti-CTLA-4 Antibodies Induces Tumor Shrinkage <i>In Vivo</i>
Elizabeth K Duperret, Aspen Trautz, Regina Stoltz, et al.
Leukemia
|
August 22, 2012
Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation
Y Bai, G Bandara, E Ching Chan, et al.
The Journal of Infectious Diseases
|
November 27, 2018
Anti-OspA DNA-Encoded Monoclonal Antibody Prevents Transmission of Spirochetes in Tick Challenge Providing Sterilizing Immunity in Mice
Yang Wang, Rianne Esquivel, Seleeke Flingai, et al.
Plos One
|
January 7, 2014
HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo
Kar Muthumani, Megan C Wise, Kate E Broderick, et al.
Cancer Immunology Research
|
September 11, 2020
A DNA-Launched Nanoparticle Vaccine Elicits CD8<sup>+</sup> T-cell Immunity to Promote <i>In Vivo</i> Tumor Control
Ziyang Xu, Neethu Chokkalingam, Edgar Tello-Ruiz, et al.
Advances in Wound Care
|
February 2, 2019
A Porcine Wound Model of <i>Acinetobacter baumannii</i> Infection
Daniel V Zurawski, Chad C Black, Yonas A Alamneh, et al.
Critical Reviews in Toxicology
|
September 18, 2013
A survey of frameworks for best practices in weight-of-evidence analyses
Lorenz R Rhomberg, Julie E Goodman, Lisa A Bailey, et al.
Cancer Research
|
April 21, 2011
The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile
Christopher A Eide, Lauren T Adrian, Jeffrey W Tyner, et al.
Page
of 34
Search research articles
Search
Showing results (291-300 of 335) with videos related to
Sort By:
Page
of 34
American Journal of Medical Genetics. Part A
|
April 20, 2021
Marfan syndrome resulting from a rare pathogenic FBN1 variant, ascertained through a proband with IgG4-related arteriopathy
Eric A Haan, Francois H Chamalaun, Steven A J Chamuleau, et al.
JCI Insight
|
April 19, 2019
DNA-encoded bispecific T cell engagers and antibodies present long-term antitumor activity
Alfredo Perales-Puchalt, Elizabeth K Duperret, Xue Yang, et al.
Cancer Research
|
October 6, 2018
Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti-CTLA-4 Antibodies Induces Tumor Shrinkage <i>In Vivo</i>
Elizabeth K Duperret, Aspen Trautz, Regina Stoltz, et al.
Leukemia
|
August 22, 2012
Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation
Y Bai, G Bandara, E Ching Chan, et al.
The Journal of Infectious Diseases
|
November 27, 2018
Anti-OspA DNA-Encoded Monoclonal Antibody Prevents Transmission of Spirochetes in Tick Challenge Providing Sterilizing Immunity in Mice
Yang Wang, Rianne Esquivel, Seleeke Flingai, et al.
Plos One
|
January 7, 2014
HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo
Kar Muthumani, Megan C Wise, Kate E Broderick, et al.
Cancer Immunology Research
|
September 11, 2020
A DNA-Launched Nanoparticle Vaccine Elicits CD8<sup>+</sup> T-cell Immunity to Promote <i>In Vivo</i> Tumor Control
Ziyang Xu, Neethu Chokkalingam, Edgar Tello-Ruiz, et al.
Advances in Wound Care
|
February 2, 2019
A Porcine Wound Model of <i>Acinetobacter baumannii</i> Infection
Daniel V Zurawski, Chad C Black, Yonas A Alamneh, et al.
Critical Reviews in Toxicology
|
September 18, 2013
A survey of frameworks for best practices in weight-of-evidence analyses
Lorenz R Rhomberg, Julie E Goodman, Lisa A Bailey, et al.
Cancer Research
|
April 21, 2011
The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile
Christopher A Eide, Lauren T Adrian, Jeffrey W Tyner, et al.
Page
of 34